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Sources of Potentially Harmful Elements in soils 
• Natural geogenic sources 
• Anthropogenic pollution 
• Point source (single 
identifiable source) 
• Diffuse pollution 
(dispersed over a wide 
area) 
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Domain Area 
(km2) 
Area 
(%) 
NBC 
(mg/kg) 
n 
Ironstone 1,300 1  220 437 
Mineralisation 2,300 2  290 187 
Principal 129,30
0 
97  32 41,50
9 
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Exposure biomarkers 
Biological markers (biomarkers) can be utilised to estimate 
levels of exposure to harmful substances. 
Following exposure, soluble arsenic is adsorbed from the 
gastro-intestinal tract and distributed to all bodily systems in 
the blood, accumulating in many body parts. 
Toenails Fingernails Hair 
Long-term (past exposure) 
Blood Urine 
Short-term (recent exposure) 
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Inhalation 
Ingestion 
Dermal contact 
Exposure 
Pathways 
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Ingestion
Absorption
What are we trying to achieve? 
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M1 Metals associated 
with soil can be 
accidentally 
ingested 
Bioaccessibility: The fraction 
of contaminant that is 
dissolved in the gastro-
intestinal tract and available 
for uptake 
Bioavailability: The fraction of 
the bioaccessible fraction that 
crosses the cell wall 
M2 
Non bioaccessible 
metals are 
excreted with 
undigested soil 
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Practicalities of the UBM 
(Version 2) 
0.6 g soil 
0.6 g soil 
Simulated Saliva 
pH = 6.5 ± 0.5 
 
Stomach 
extractant 
pH = 0.9/1.0 
End-over-end    
1 hour 
pH =1.2 ± 0.05 
Intestinal extractant 
End-over-end     
4 hours 
pH =6.3 ± 0.5 pH = 6.3 ± 0.5 
 
Centrifuge (4500 g, 
15 min). Analysis 
by ICP-MS 
Gastric sample 
Gastro-Intestinal sample 
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The UBM method 
Stomach and Intestine reagents are 
prepared according to the protocol
Soil samples are weighed into 
centrifuge tubes
Soils are extracted with gastric 
and intestine solutions in a water 
bath at 37
0
 C
Samples are CentrifugedDecanted samples are diluted and 
preserved in 
0.1 M HNO3
Samples are 
analysed by ICP-
AES 
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Comparison of in vivo and in vitro data for NIST 2710 
for the UBM inter-laboratory trial (2006/2007)  
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Summary of the RBA vs RBAc regression statistics for the four end 
points for As. Black squares show data for the ‘stomach’ phase and 
white triangles for the ‘stomach & intestine’ phase. Error bars 
represent 95% confidence limits dotted lines show benchmark values. 
As 
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(b)
correlation plots for RBAc against RBA for (a) Pb and (b) Cd for the 
‘stomach’ and ‘stomach & intestine’ phases for the kidney endpoint. 
Bold dashed dotted line is the line of equivalence, dashed lines are 
the 95% confidence intervals and the solid lines is the best line of fit 
 
Pb 
Cd 
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correlation plots for RBAc against RBA for (c) As and (d) Sb for the ‘stomach’ 
and ‘stomach & intestine’ phases for the urine end point. Bold dashed dotted 
line is the line of equivalence, dashed lines are the 95% confidence intervals 
and the solid line is the best line of fit. 
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How are PHE distributed in the soil components? 
 
CISED Test 
Chemometric Identification of Substrates and Element 
Distributions  
•Separate aliquots of aqua regia of 
increasing concentration.  
•Passed through the sample under 
centrifugal force.   
•Determination by ICP-AES. 
•Chemometric data processing . 
•Identification of physico-chemical 
hosts and the metal distributions within 
the sample under test. 
Centrifugation 
0.45 m 
filter 
membrane leachate 
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Example output of CISED 
0 20 40 60 80
Ca
K -Ca
Mn-Al
Al-Fe
Ca-Al
Fe-Na-Si-P 
Fe
Fe-Al
Pb
mg kg
-1
0 5 10 15 20 25
Ca
K -Ca
Mn-Al
Al-Fe
Ca-Al
Fe-Na-Si-P 
Fe
Fe-Al
As
mg kg
-1
Fe oxide
Mn oxide
Carbonate
Al oxide
Carbonate2
Residual solutes
Fe oxide
Organics
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Comparison of the Relative Bioaccessibility of As in 
the UK 
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Scatterplot of LnBSAs vs LnAs: UBM analysis
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Bioaccessible Pb in London Soil 
Appleton J, Cave M, Wragg J. Modelling lead bioaccessibility in urban topsoils 
based on data from Glasgow, London, Northampton and Swansea, UK. 
Environmental Pollution 2012. 
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Organics 
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Added Difficulties for Organics 
• Addition of food 
• Glassware 
• Analysis (aqueous/organic phases)  
• Metabolites 
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FOREhST 
Fed ORganic Extraction human Simulation 
Test 
• BGS has modified the RIVM fed 
state model and combined this 
with an optimised method for 
PAH analysis.  
• We have developed a robust 
procedure for PAH in the 
extraction matrix that could be 
used by a testing laboratory. 
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FOREhST 
• Simulated the nutritional status of a 2-
3 yr old 
• Only intestine phase sampled  
• PAH separation and analysis by 
HPLC-Fluorescence detection 
• PAHs investigated 
• Benzo(a)anthracene; 
   Benzo(b and k)fluoranthene; 
Benzo(a)pyrene; 
Dibenzo(ah)anthracene; 
Indeno(123cd)pyrene. 
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PAH name MW log Kow PAH No
Benz(a)-anthracene 228 5.61 1
Benzo(b)-fluoranthene 252 6.04 2
Benzo(k)-fluoranthene 252 6.06 3
Benzo(a)-pyrene 252 6.06 4
Dibenz(ah)-anthracene 278 6.5 5
Indeno(123cd)-pyrene 276 6.58 6
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Follow up Study 
• 26 soil samples from 3 gas works sites of varying 
ages  
• 8 samples from a small horizontal gasworks that 
was closed in 1950 
• 5 samples from an uncontaminated urban garden,  
• 4 samples from a small gasworks which was closed 
1900 and  
• 9 samples from an early small gasworks closed in 
1860  
• The samples were freeze dried and sieved to <250 
µm. Total PAH and FOREhST extractions 
• NIR and Mid-IR spectra of the soils      
 
© NERC All rights reserved 
PAHs studied 
N naphthalene   
Ay acenaphthylene   
Ae acenaphthene   
F fluorene    
Ph phenanthrene   
An anthracene   
Fl fluoranthene   
Py pyrene    
BaA benz[a]anthracene  
Ch chrysene   
BbF benzo[b]fluoranthene  
BkF benzo[k]fluoranthene  
BjF benzo[j]fluoranthene  
BeP benzo[e]pyrene   
BaP benzo[a]pyrene   
Per perylene    
IdPy indeno[1,2,3-cd]pyrene  
DBA dibenz[a,h]anthracene  
BPer benzo[ghi]perylene 
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Model of PAH 
Bioaccessibility 
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Model Interpretation 
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Model Predictions 
Able to predict BA values for PAHs not analysed 
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Second study 
explains first 
study 
anomalies 
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Conclusions 
• Quantification is essential – validated methods are 
desirable before bioavailability/bioaccessibility 
research can be attempted (How?).  
•  It is not enough to measure “how much” but we 
also need to understand what makes the 
contaminant bioavailable (Why?)   
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